Using a self-collect device for cervical cancer screening
Evaluation of the Teal self-collect device for cervical cancer screening
This study is looking at a new device called the Teal Wand that lets women collect their own samples at home for HPV testing, making it easier for them to get screened for cervical cancer, especially if they have trouble accessing traditional healthcare.
Quick facts
| Grant type | Sbir 2 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Teal Health INC NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project ID | NIH-11008315 on NIH RePORTER |
What this research studies
This research investigates the Teal self-collect device, which allows women to collect their own vaginal samples for HPV testing, a key factor in cervical cancer prevention. The device features a textured sponge designed to gather sufficient cellular material and preserve samples for accurate testing. By enabling at-home sample collection, the Teal Wand aims to increase participation in cervical cancer screening, particularly among women facing access barriers. The study seeks FDA approval for this innovative device to facilitate telehealth visits and improve preventive care access.
Who could benefit from this research
Good fit: Ideal candidates for this research are women who are eligible for cervical cancer screening and may benefit from at-home testing options.
Not a fit: Patients who have already been diagnosed with cervical cancer or those who do not require screening will not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly increase cervical cancer screening rates among women, particularly those with limited access to traditional healthcare services.
How similar studies have performed: Similar approaches to self-collection for HPV testing have shown promise in increasing screening rates, indicating potential success for this novel device.
Where this research is happening
San Francisco, United States
- Teal Health INC — San Francisco, United States (Active)
Researchers
- Principal investigator: Fitzpatrick, Megan — Teal Health INC
- Study coordinator: Fitzpatrick, Megan
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.